AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Siglyn M IR 50/1000 Tablet

Prescription Icon
Prescription Required

Marketer

Zydus Healthcare Limited

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Siglyn M IR 50/1000 Tablet

Duo-Med, a 50/1000 mg tablet, combines two agents to manage elevated blood glucose in type 2 diabetes. This helps prevent serious diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risk. Duo-Med may be used alone or with other diabetes treatments, and is most effective when paired with a balanced diet and regular physical activity. Dosage is individualized based on your health, blood sugar readings, and other medications. Taking it with food minimizes stomach upset. Consistent daily dosing, at the same time each day, maximizes effectiveness; discontinue only under your doctor's guidance. Maintaining your prescribed diet and exercise plan is crucial. Lifestyle significantly impacts diabetes control. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Low blood sugar (hypoglycemia) is a potential risk, especially with concurrent insulin or sulfonylurea use; learn its recognition and management. This medication isn't for everyone. Inform your doctor of any history of kidney, liver, or heart disease, pancreatic issues, or excessive alcohol consumption before starting. Pregnant or breastfeeding individuals should consult their physician. Other medications may interact with Duo-Med; disclose all your medications for safety. Alcohol should be limited due to its blood glucose-lowering effect. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Uses of Siglyn M IR 50/1000 Tablet

Managing Type 2 diabetes

Major Benefits of Siglyn M IR 50/1000 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Siglyn M IR 50/1000 Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

Common Side effects of Siglyn M IR 50/1000 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Siglyn M IR 50/1000 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Siglyn M IR 50/1000 with a meal.

How Siglyn M IR 50/1000 Tablet works:

Siglyn M IR 50/1000 tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and heightens insulin sensitivity. This dual action results in improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Siglyn M IR 50/1000 Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Siglyn M IR 50/1000 tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Siglyn M IR 50/1000 tablets while breastfeeding is likely inadvisable. Preliminary research in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving should these conditions arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Siglyn M IR 50/1000 Tablets, potentially requiring dosage modification. Consultation with a physician is advised. The medication is contraindicated for those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

The use of Siglyn M IR 50/1000 Tablets is contraindicated in individuals with hepatic impairment and should be strictly avoided. Medical advice is recommended.

What if you forget to take Siglyn M IR 50/1000 Tablet :

Should you forget a Siglyn M IR 50/1000 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Siglyn M IR 50/1000 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Siglyn M IR 50/1000 Tablet

Siglyn M IR 50/1000 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of Siglyn M IR 50/1000 Tablet can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues like tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Siglyn M IR 50/1000 Tablet may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Siglyn M IR 50/1000 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Siglyn M IR 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (like Siglyn M IR 50/1000) can rarely cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA—Metformin-associated lactic acidosis). This risk is increased in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If experienced, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Siglyn M IR 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Siglyn M IR 50/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Siglyn M IR 50/1000 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Siglyn M IR 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Yes, taking Sitagliptin + Metformin (like Siglyn M IR 50/1000 Tablet) can rarely cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, Metformin-associated lactic acidosis). This risk is higher in patients with kidney disease, older adults, and heavy alcohol users, so it's avoided in these groups. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Siglyn M IR 50/1000 Tablet can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and urinary issues), and cognitive changes including balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Siglyn M IR 50/1000 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Siglyn M IR 50/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Siglyn M IR 50/1000 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol while taking Siglyn M IR 50/1000 Tablet is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Siglyn M IR 50/1000) can, rarely, cause lactic acidosis—a serious condition with elevated blood lactic acid levels (also called Metformin-associated lactic acidosis, or MALA). This risk is higher in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Siglyn M IR 50/1000 Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Siglyn M IR 50/1000 Table...
124